31 May
2016
Seminar: Developability Assessment of therapeutic Antibodies - A concept for early Lead Selection | Thorsten Lorenz, PhD - Novartis Pharma AG
iBET|ITQB Auditorium, Oeiras 12:0013:00Group Head Developability Assessment 1, Integrated Biologics Profiling,
Novartis Pharma AG, Basel – Switzerland.